Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Fortress Biotech (FBIO) Return on Equity (2016 - 2025)

Historic Return on Equity for Fortress Biotech (FBIO) over the last 13 years, with Q3 2025 value amounting to 1.38%.

  • Fortress Biotech's Return on Equity fell 100600.0% to 1.38% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.38%, marking a year-over-year decrease of 100600.0%. This contributed to the annual value of 5.34% for FY2024, which is 10900.0% down from last year.
  • As of Q3 2025, Fortress Biotech's Return on Equity stood at 1.38%, which was down 100600.0% from 2.9% recorded in Q2 2025.
  • Fortress Biotech's Return on Equity's 5-year high stood at 12.03% during Q3 2023, with a 5-year trough of 112.78% in Q2 2023.
  • In the last 5 years, Fortress Biotech's Return on Equity had a median value of 1.38% in 2025 and averaged 9.08%.
  • In the last 5 years, Fortress Biotech's Return on Equity tumbled by -1115400bps in 2023 and then surged by 1238600bps in 2024.
  • Quarter analysis of 5 years shows Fortress Biotech's Return on Equity stood at 0.84% in 2021, then plummeted by -226bps to 2.75% in 2022, then plummeted by -1048bps to 31.62% in 2023, then rose by 27bps to 23.21% in 2024, then skyrocketed by 94bps to 1.38% in 2025.
  • Its last three reported values are 1.38% in Q3 2025, 2.9% for Q2 2025, and 3.69% during Q1 2025.